Found: 7
Select item for more details and to access through your institution.
Integrating digital gait data with metabolomics and clinical data to predict outcomes in Parkinson's disease.
- Published in:
- NPJ Digital Medicine, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s41746-024-01236-z
- By:
- Publication type:
- Article
Gut microbiome is not associated with mild cognitive impairment in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00687-1
- By:
- Publication type:
- Article
Comprehensive blood metabolomics profiling of Parkinson's disease reveals coordinated alterations in xanthine metabolism.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00671-9
- By:
- Publication type:
- Article
Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson's study.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00595-w
- By:
- Publication type:
- Article
Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer.
- Published in:
- British Journal of Cancer, 2018, v. 119, n. 5, p. 580, doi. 10.1038/s41416-018-0200-0
- By:
- Publication type:
- Article
Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mixed effects models but not t-tests or linear regression detect progression of apathy in Parkinson's disease over seven years in a cohort: a comparative analysis.
- Published in:
- BMC Medical Research Methodology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12874-024-02301-7
- By:
- Publication type:
- Article